MedPath

ACETAMINOPHEN AND CODEINE

ACETAMINOPHEN AND CODEINE

Approved
Approval ID

720570a4-9eec-41c8-ae69-37189756c318

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 29, 2023

Manufacturers
FDA

DIRECT RX

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ACETAMINOPHEN AND CODEINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-023
Application NumberANDA040779
Product Classification
M
Marketing Category
C73584
G
Generic Name
ACETAMINOPHEN AND CODEINE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 29, 2023
FDA Product Classification

INGREDIENTS (10)

CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ACETAMINOPHENActive
Quantity: 300 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
CODEINE PHOSPHATEActive
Quantity: 30 mg in 1 1
Code: GSL05Y1MN6
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACETAMINOPHEN AND CODEINE - FDA Drug Approval Details